Haemonetics (HAE) Competitor Comparison
We are evaluating the key criteria listed to compare Haemonetics (HAE) against its competitors in the Medical Instruments & Supplies industry.
Market Capitalization
17 / 44Gross Profits
0 / 40Total Revenue
17 / 43EBITDA
16 / 44Free Cashflow
12 / 44Quick Ratio
24 / 44Earnings per Share
10 / 44Dividend yield
0 / 13Total Cash
12 / 44Performance 3 years
5 / 44Performance 5 years
26 / 44Performance 10 years
18 / 44Linearity 3 years
20 / 44Linearity 5 years
17 / 44Linearity 10 years
22 / 44Total Rank
35 / 44Dividend Rank
41 / 44Valuation Rank
16 / 44Piotroski Rank
13 / 44Muliplier Rank
14 / 44Performance 3 years - HAE ranking 5 / 44
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.